The global Nucleic Acid Isolation And Purification Market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.
Ongoing developments of automated nucleic acid extraction
systems designed for high-throughput sample processing have significantly
simplified the isolation of DNA and RNA, thereby providing lucrative avenues
for market growth. These systems potentially reduce the labor costs and time,
increase worker safety, laboratory efficiency, reproducibility, and quality of
results.
The growing popularity of biopharmaceuticals has led to
the development of nucleic acid-based products, such as DNA vaccines, small
interfering RNA, and antisense oligonucleotides. These products are applied in
therapeutic techniques, such as gene therapy and anti-sense technology, as a
powerful tool for medical practitioners to treat cancer, genetic, and
infectious diseases. This has boosted the adoption of DNA or RNA isolation
techniques in the market.
Request a
free sample copy or view report summary: Nucleic Acid Isolation And Purification Market Report
Nucleic Acid Isolation And Purification Market Report
Highlights
- The instruments segment is expected to grow at a lucrative pace due
to the advent of automated extraction systems resulting in high
performance and lower cost for DNA extraction
- DNA isolation methods accounted for the largest revenue share and
are anticipated to witness the fastest progress rate due to ongoing
discoveries of simple, rapid, and inexpensive methods
- The high adoption rate of magnetic bead methods is attributive to
its largest revenue share
- This is because the method can isolate nucleic acids directly from
the crude sample without much processing
- This method is also expected to witness the fastest CAGR owing to
the development of functionalized magnetic particles that have been
incorporated in buffer systems to provide rapid and efficient extraction
- Oncology application is projected to witness a lucrative growth
rate as liquid biopsy techniques and patient-tailored therapies are
gaining traction for cancer diagnosis
- Hospitals and diagnostic centers accounted for the largest share in
2019, in terms of revenue
- The high incidence rate of genetic and inherited diseases has
increased the usage of nucleic acid isolation in early and accurate
diagnosis of these conditions in hospitals
- Better healthcare infrastructure, a substantial number of
technology providers, and rapid adoption of NGS has driven the uptake of
nucleic acid extraction products in North America at a large scale
- Asia Pacific is anticipated to exhibit the fastest CAGR over the
forecast period owing to significant public and private commitments
towards genomics research and precision medicine, thereby prompting the adoption
of isolation techniques
- QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo
Fisher are some key companies operating in the nucleic acid isolation and
purification market.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment